Showing results (2021-2030 of 2,175) with videos related to
Sort By:
Pageof 218
Physiological Genomics|September 19, 2019
Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndromeLydia Coulter Kwee, Megan L Neely, Elizabeth Grass, et al.JACC. Heart Failure|May 3, 2023
Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIAJaved Butler, Yinggan Zheng, Muhammad Shahzeb Khan, et al.JAMA|November 17, 2014
Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarctionDuk-Woo Park, Robert M Clare, Phillip J Schulte, et al.Clinical Chemistry|May 19, 2017
Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary SyndromeMark Y Chan, Megan L Neely, Matthew T Roe, et al.American Heart Journal|December 5, 2009
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trialJeffrey S Berger, Matthew T Roe, C Michael Gibson, et al.Clinical Ophthalmology (Auckland, N.Z.)|May 13, 2025
Demographic and Clinical Factors Associated with Mechanisms of Open Globe Injury in the United States: A Multi-Center StudyShruti Anant, Alicia Casella, Jason A Greenfield, et al.Circulation|May 22, 2002
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluationChristopher K Dyke, Richard C Becker, Neal S Kleiman, et al.Circulation|June 20, 2017
Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)Neha J Pagidipati, Ann Marie Navar, Karen S Pieper, et al.American Heart Journal|February 3, 2009
Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)Adrian F Hernandez, Christopher M O'Connor, Randall C Starling, et al.Pageof 218